ETON

Eton Pharmaceuticals Inc.

Price

$61.48

return (12m)

279.51%

p/e

125.87

p/bv

34.26

DIVIDEND YIELD

0.00%

ETON price

Eton Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ETON

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

40.64%

3 months

75.66%

1 year

279.51%

2 years

1,421.78%

5 years

1,294.10%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ETON

Valuation

P/E

125.87

Sector -2.19

Industry 1.21

P/BV

34.26

Sector 2.22

Industry 2.11

P/Revenue (PSR)

15.11

Sector 2.01

Industry 0.78

EV/EBITDA

112.01

Sector -17.81

Industry -25.30

EV/EBIT

124.18

Sector -26.72

Industry -18.04

P/EBITDA

76.51

Sector 0.36

Industry 0.18

P/EBIT

97.91

Sector -3.34

Industry 1.26

P/Total Assets

13.78

Sector 1.23

Industry 0.86

P/Net Current Assets

-2,574.19

Sector -27.35

Industry -12.37

P/Working Capital

67.97

Sector -4.54

Industry -49.48

EPS

0.45

Sector -0.87

Industry -0.55

BVPS

1.66

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

57.86%

Sector 43.36%

Industry 31.53%

EBITDA Margin

37.72%

Sector -323.65%

Industry -73.39%

EBIT Margin

34.03%

Sector -194.57%

Industry -11.94%

Operating Margin

15.44%

Sector -24.37%

Industry -9.87%

Net Profit Margins

12.01%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.32

Sector 0.12

Industry 0.22

Profitability

ROE

27.22%

Sector -33.82%

Industry -37.56%

ROA

10.95%

Sector -29.63%

Industry -17.56%

ROIC

90.05%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.52

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-0.55

Sector -1.47

Industry -31.86

Net Debt / EBIT

-0.61

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.17

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.41

Sector 0.14

Industry 0.51

Equity/Assets

0.40

Sector 0.42

Industry 0.25

Liabilities/Assets

0.60

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

37.05%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Eton Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$61.48

Fair Value

$4.10

Upside Return potential.

-93.33%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ETON

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ETON Eton Pharmaceuticals Inc.	$61.48	275.57%	0.00%	125.87	34.26	27.22%	12.01%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ETON Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Eton Pharmaceuticals

Eton Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

9 years

Founded: 2017

2018

Time since IPO - 8 years

16

Employees

Eton Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.60 billion, with shareholders equity totaling $46.59 million.

The company employs approximately 16 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Eton Pharmaceuticals Inc. reported $105.60 million in revenue, generating net income of $12.68 million.

Key financial metrics include a P/E ratio of 125.87, a price-to-book (P/B) ratio of 34.26, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ETON.

Market cap

$1.60 billion

Net worth

$46.59 million

$46,590,000.00

Assets

$115.81 million

$115,810,000.00

Total Shares Outstanding

28.00 million

28,000,000

Average Daily Trading Volume

$516.78 Thousand

$516,784.30

Sector

Health

Industry

Pharmaceutical Products

ETON

ETON revenue and profits

Financial Results ETON

DRAG THE FRAME TO SEE MORE DATA

ETON cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87